# Johnson & Johnson (JNJ) — News

JNJ · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/jnj/news

## Recent headlines

- [Wells Fargo raises healthcare stocks to overweight](https://www.ainvest.com/news/wells-fargo-raises-healthcare-stocks-overweight-2609) — AInvest Wire, Sep 15, 2026
  Wells Fargo & Company has recently adjusted its stance on several healthcare stocks, upgrading them to "Overweight" status, indicating a favorable outlook for these companies. Among the notable upgrades is Johnson & Johnson (JNJ), which was elevated from "Equal Weight" to "Overweight" on September…
- [Johnson & Johnson shares rise on Apollo global takeover talks - Investing](https://www.ainvest.com/news/johnson-johnson-shares-rise-apollo-global-takeover-talks-investing-2609) — AInvest Wire, Sep 14, 2026
- [J&J shares up 2% after report co's orthopedics unit draws Apollo interest in potential $20 bln deal](https://www.ainvest.com/news/shares-2-report-orthopedics-unit-draws-apollo-interest-potential-20-bln-deal-2609) — AInvest Wire, Sep 14, 2026
  Johnson & Johnson shares rose 2% in after-hours trading on Friday following reports that Apollo Global Management is in early-stage discussions to acquire the orthopedics unit for approximately $20 billion. The potential transaction, if finalized, would represent one of the largest private equity…
- [J&J shares up 1.2% premarket after report co's orthopedics unit draws Apollo interest in potential $20 bln deal](https://www.ainvest.com/news/shares-1-2-premarket-report-orthopedics-unit-draws-apollo-interest-potential-20-bln-deal-2609) — AInvest Wire, Sep 14, 2026
  Johnson & Johnson (NYSE: JNJ) shares rose 1.2% in premarket trading on September 14, 2026, following a report that Apollo Global Management is considering potential $20 billion acquisition of J&J’s orthopedics unit. The unit, which includes a range of orthopedic devices and surgical solutions, has…
- [Apollo is said to be in talks to acquire J&J's orthopedics unit](https://www.ainvest.com/news/apollo-talks-acquire-orthopedics-unit-2609) — AInvest Wire, Sep 11, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).